These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1161356)

  • 1. [Phenylketonuria. IV. Therapeutic results in late-diagnosed phenylketonuria].
    Cabalska B; Borzymowska J; Golabek B; Dawydzik B; Miesowicz I; Retko I; Zorska K
    Pediatr Pol; 1975 Aug; 50(8):953-62. PubMed ID: 1161356
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the treatment of phenylketonuria with a low-phenylalanine protein hydrolysate produced by VEB Berlin-Chemie].
    Cobet G; Hübschmann K
    Dtsch Gesundheitsw; 1966 Jun; 21(22):1018-24. PubMed ID: 5973617
    [No Abstract]   [Full Text] [Related]  

  • 3. [Specialized food products for patients with phenylketonuria].
    Bushueva TV; Rybakova EP
    Vopr Pitan; 1993; (2):58-61. PubMed ID: 8042302
    [No Abstract]   [Full Text] [Related]  

  • 4. [Economics of prevention and therapy as shown on the example of phenylketonuria].
    Cobet G; Lachmann B; Matthias M
    Z Arztl Fortbild (Jena); 1972 Aug; 66(16):821-7. PubMed ID: 4636582
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of phenylketonuria. Principles, management and importance of a phenylalanine-free protein hydrolysate].
    Boisse J; Saudubray JM; Cathy T; Mozziconacci P
    Ann Pediatr (Paris); 1971 Feb; 18(2):109-17. PubMed ID: 5549952
    [No Abstract]   [Full Text] [Related]  

  • 6. [Phenylketonuria. II. Treatment].
    Cabalska B; Duczyńska N
    Pediatr Pol; 1967 Oct; 42(10):1193-201. PubMed ID: 6082499
    [No Abstract]   [Full Text] [Related]  

  • 7. [Usefulness of protein hydrolysates for the dietary treatment of phenylketonuria].
    Cobet G; Koch R
    Padiatr Grenzgeb; 1984; 23(4):217-24. PubMed ID: 6483448
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and electroencephalographic features of the convulsive syndrome in phenylketonuria in children].
    Bliumina MG; Lebedev BV; Mirzoiants NS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(10):1540-3. PubMed ID: 5369953
    [No Abstract]   [Full Text] [Related]  

  • 9. [Our experiences with treatment of phenylketonuria].
    Tresohlavá Z; Brachfeld K; Svatý J
    Cesk Pediatr; 1969 Jun; 24(6):522-8. PubMed ID: 5792287
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phenylalanine tolerance and results of oral phenylalanine load in children with phenylketonuria in various ages].
    Bührdel P; Theile H
    Kinderarztl Prax; 1975 Nov; 43(11):501-8. PubMed ID: 1214334
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of early started dietetic treatment on the bioelectric brain activity in children with phenylketonuria].
    Koślacz-Folga A; Cabalska B; Jackowska K
    Neurol Neurochir Pol; 1974; 8(6):815-21. PubMed ID: 4437712
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical analysis of 74 cases of phenylketonuria and hyperphenylalanemia].
    Dong GZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Feb; 19(1):49-51. PubMed ID: 3743248
    [No Abstract]   [Full Text] [Related]  

  • 13. [Phenylketonuria : early diagnosis and mental development. Pilot study on 89 phenylketonuric children with start of the diet from the 1st up to and including the 12th month of life].
    Schmid-Rüter E; Grubel-Kaiser S
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):479-81. PubMed ID: 876210
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phenylalanine-restricted diet: the substitutes].
    Ogier H; Depondt E; Munnich A; Saudubray JM
    Arch Fr Pediatr; 1983; 40 Suppl 1():247-50. PubMed ID: 6882142
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of dietetic treatment in phenylketonuria after late detection].
    Prişcu R; Popescu V; Sichitiu S; Stroia V; Caniola I; Ciofu E; Diaconu T; Vlăsceanu S; Milcu M
    Rev Pediatr Obstet Ginecol Pediatr; 1976; 25(1):19-28. PubMed ID: 821121
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of children with phenylketonuria using a phenylalanine-free protein hydrolysate (Albumaid XP).
    Berry HK; Sutherland BS; Hunt MM; Fogelson MH; O'Grady D
    Am J Clin Nutr; 1976 Apr; 29(4):351-7. PubMed ID: 1266784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of phenylketonuria with a new phenylalanine-free protein hydrolysate (Albumaid XP). II. Practical application and effect on weight, height and bone development in 21 days].
    Saudubray JM; Boisse J; Strouck J; Caty T; Lery E; Mozziconacci P
    Ann Pediatr (Paris); 1972; 19(6):469-80. PubMed ID: 4341582
    [No Abstract]   [Full Text] [Related]  

  • 18. The sex ratio in phenylketonuria.
    Blyumina MG
    Sov Genet; 1974 Mar; 7(12):1604-7. PubMed ID: 4827772
    [No Abstract]   [Full Text] [Related]  

  • 19. [Success of diet therapy in phenylketonuria using the phenylalanine-low protein hydrolysate Berlin-Chemie. 3. Psychologic examination results].
    Kunze C; Theile H
    Dtsch Gesundheitsw; 1970 Feb; 25(5):213-8. PubMed ID: 5422755
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with treatment of children with phenylketonuria].
    Lebedev BV; Bliumina MG; D'iachkova AIa; Blagoslavova EI; Mirzoiants NS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(10):1521-5. PubMed ID: 5369950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.